Archangels
investing in innovation
?>


Reactec wins major contract with Network Rail

Reactec, the market leader in monitoring and management solutions for hand and arm vibration (HAV) – one of the most common industrial diseases in the UK – has won a …

SaaS training solution Administrate one of the fastest growing Scottish tech companies in 2015

Introduction of pioneering 4-day week increases productivity and wellbeing Voted #1 Learning Management System (LMS) by industry leader $2.5 million round funds next phase of growth    December 18, Edinburgh …

Archangels appoints new board member

  Scottish-based business angel syndicate, Archangels, has appointed former Baillie Gifford & Co Partner, Michael MacPhee, to its board of directors.   Having been called to the English Bar in …

Archangels and Scottish Investment Bank support three Scottish Businesses with further funding

Scottish-based business angel syndicate, Archangels, and the Scottish Investment Bank (SIB) have supported the investment of a further £2m in three growing Scottish businesses in the third quarter of 2015. …

Bloxx acquired by Akamai Technologies, Inc.

Livingston-based Bloxx, the provider of real-time Internet and email filtering solutions, has been sold by its shareholders – including Archangel Investors and Scottish Investment Bank – to US-based Akamai Technologies, …

Archangels Impact Evaluation Report

We are delighted that Deputy First Minister John Swinney, MSP will be joining us at the Strathclyde University Technology and Innovation Centre in Glasgow to launch the findings of a …

Dundee-based CXR Biosciences Joins Concept Life Sciences Group

CXR Biosciences Limited, (“CXR”) the Dundee-based investigative and exploratory toxicology business, has been sold by its shareholders – including Archangel Investors and Scottish Investment Bank – to UK-based Concept Life …

MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the treatment of multi-resistant Clostridium Difficile infections

MGB Biopharma is at the forefront of efforts to tackle the global rise in antibiotic resistant infections Glasgow, Scotland, 21st July 2015 – MGB Biopharma, a biopharmaceutical company developing a …

MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the treatment of multi-resistant Clostridium Difficile infections

MGB Biopharma is at the forefront of efforts to tackle the global rise in antibiotic resistant infections Glasgow, Scotland, 21st July 2015 – MGB Biopharma, a biopharmaceutical company developing a …

NCTech on the News!

Click on the link to see Neil Tocher from NCTech talking about their new Iris360 camera and a new project with Google Street View. NCTech on STV. For more information …